500126 Stock Overview
Procter & Gamble Health Limited engages in the manufacture and marketing of pharmaceuticals and chemical products in India and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Procter & Gamble Health Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹4,736.35 |
| 52 Week High | ₹5,640.00 |
| 52 Week Low | ₹4,595.85 |
| Beta | 0.45 |
| 1 Month Change | -3.10% |
| 3 Month Change | -10.11% |
| 1 Year Change | 0.99% |
| 3 Year Change | -26.53% |
| 5 Year Change | 27.41% |
| Change since IPO | 115,139.66% |
Recent News & Updates
Recent updates
Shareholder Returns
| 500126 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 0.4% | -0.5% | 1.4% |
| 1Y | 1.0% | 55.3% | 46.1% |
Return vs Industry: 500126 underperformed the Indian Pharmaceuticals industry which returned 55.3% over the past year.
Return vs Market: 500126 underperformed the Indian Market which returned 46.1% over the past year.
Price Volatility
| 500126 volatility | |
|---|---|
| 500126 Average Weekly Movement | 2.8% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.8% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 500126 has not had significant price volatility in the past 3 months.
Volatility Over Time: 500126's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1967 | 1,407 | Milind Thatte | www.pghealthindia.com |
Procter & Gamble Health Limited engages in the manufacture and marketing of pharmaceuticals and chemical products in India and internationally. The company provides over-the-counter products, vitamins, minerals, and supplements. It offers its products under the Cosome, Polybion, Neurobion, Evion, Nasivion, Livogen, and Seven Seas brands.
Procter & Gamble Health Limited Fundamentals Summary
| 500126 fundamental statistics | |
|---|---|
| Market cap | ₹78.20b |
| Earnings (TTM) | ₹2.27b |
| Revenue (TTM) | ₹12.37b |
34.7x
P/E Ratio6.4x
P/S RatioIs 500126 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 500126 income statement (TTM) | |
|---|---|
| Revenue | ₹12.37b |
| Cost of Revenue | ₹3.93b |
| Gross Profit | ₹8.44b |
| Other Expenses | ₹6.17b |
| Earnings | ₹2.27b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 02, 2024
| Earnings per share (EPS) | 136.54 |
| Gross Margin | 68.23% |
| Net Profit Margin | 18.32% |
| Debt/Equity Ratio | 0% |
How did 500126 perform over the long term?
See historical performance and comparison